HK1252217A1 - 修飾的nk細胞及其用途 - Google Patents
修飾的nk細胞及其用途Info
- Publication number
- HK1252217A1 HK1252217A1 HK18111454.6A HK18111454A HK1252217A1 HK 1252217 A1 HK1252217 A1 HK 1252217A1 HK 18111454 A HK18111454 A HK 18111454A HK 1252217 A1 HK1252217 A1 HK 1252217A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cells
- modified
- Prior art date
Links
- 210000000822 natural killer cell Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/53—Liver
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/59—Reproductive system, e.g. uterus, ovaries, cervix or testes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4613—Natural-killer cells [NK or NK-T]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762446106P | 2017-01-13 | 2017-01-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1252217A1 true HK1252217A1 (zh) | 2019-05-24 |
Family
ID=62868480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18111454.6A HK1252217A1 (zh) | 2017-01-13 | 2018-09-06 | 修飾的nk細胞及其用途 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20180221463A1 (zh) |
CN (1) | CN108300699A (zh) |
HK (1) | HK1252217A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019200586A1 (en) * | 2018-04-19 | 2019-10-24 | The Chinese University Of Hong Kong | Modified nk cells and uses thereof |
CN110575535A (zh) * | 2019-10-29 | 2019-12-17 | 吉林大学 | 人激活素在制备调控nk细胞向组织局部迁移的药物中的应用 |
JP2023547695A (ja) * | 2020-11-03 | 2023-11-13 | ハンチョウ キハン バイオテック カンパニー リミテッド | 増強された免疫療法のためのシステムおよび方法 |
TW202325844A (zh) * | 2021-11-03 | 2023-07-01 | 中國大陸商杭州啟函生物科技有限公司 | 增強免疫療法的系統和方法 |
CN116726198B (zh) * | 2023-03-13 | 2024-02-13 | 陕西师范大学 | 一种抗肿瘤药物及其在脑胶质瘤治疗中的应用 |
CN116549480B (zh) * | 2023-06-16 | 2024-04-05 | 呈诺再生医学科技(北京)有限公司 | 针对HIF1α的shRNA在制备治疗肿瘤的药物中的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140120116A1 (en) * | 2012-10-26 | 2014-05-01 | The Chinese University Of Hong Kong | Treatment of cancer using smad3 inhibitor |
IL287051B (en) * | 2015-03-27 | 2022-09-01 | Immunitybio Inc | nk-2 cells and genetically engineered monoclonal antibodies for cancer treatment |
EP3328399B1 (en) * | 2015-07-31 | 2023-12-27 | Regents of the University of Minnesota | Modified cells and methods of therapy |
WO2019200586A1 (en) * | 2018-04-19 | 2019-10-24 | The Chinese University Of Hong Kong | Modified nk cells and uses thereof |
-
2018
- 2018-01-05 US US15/863,159 patent/US20180221463A1/en not_active Abandoned
- 2018-01-10 CN CN201810021212.6A patent/CN108300699A/zh active Pending
- 2018-09-06 HK HK18111454.6A patent/HK1252217A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN108300699A (zh) | 2018-07-20 |
US20180221463A1 (en) | 2018-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1250741A1 (zh) | 修飾的γδ細胞及其用途 | |
EP3472208C0 (en) | T-LYMPHOCYTE RECEPTORS AND THEIR USES | |
EP3707248A4 (en) | MODIFIED IMMUNE CELLS AND THEIR USES | |
IL273236A (en) | Pyrazolopyrimidine compounds and their uses | |
SG10201912825XA (en) | Genetically modified cells and uses thereof | |
IL249970A0 (en) | Gamma delta T cells and their uses | |
IL269334A (en) | Improved compositions of t cells and methods | |
IL277673A (en) | Transgenic cells and their uses | |
HK1252217A1 (zh) | 修飾的nk細胞及其用途 | |
IL259202A (en) | Modified immune cells and their use | |
EP3623467A4 (en) | HIGHLY ACTIVE NK CELL AND ITS USE | |
IL265962A (en) | Modified non-cytotoxic cells and their use | |
GB2563869B (en) | Materials and methods | |
GB201706808D0 (en) | Modified complement proteins and uses thereof | |
IL273247A (en) | New cell row and its uses | |
IL269237A (en) | Hypoxic NK cells and methods related thereto | |
SG11202002224XA (en) | Composition and uses thereof | |
SG11201912432VA (en) | Emm-23 materials and processes and uses thereof | |
IL275211A (en) | Fast and flexible segment chains - division | |
GB201519800D0 (en) | Peptide-induced nk cell activation | |
SG11202005282VA (en) | Emm-31 materials and processes and uses thereof | |
EP3594327A4 (en) | CELL AND ASSOCIATED USE | |
GB201620194D0 (en) | Electrode and electrchemical cell comprising the same | |
ZA201804658B (en) | Copolymers and uses thereof | |
GB201616232D0 (en) | Novel cell line and uses thereof |